Intelligent Bio Solutions Inc. (INBS) vs Telesis Bio Inc. (TBIO)

Intelligent Bio Solutions Inc. and Telesis Bio Inc. are both Medical Devices companies. Intelligent Bio Solutions Inc. and Telesis Bio Inc. are of similar size ($5.7M and $5.3M). Intelligent Bio Solutions Inc. grew revenue faster over the last twelve months: 38.1% against −38.1%. Telesis Bio Inc. has the higher net margin (−287.9% vs −294.9%) and the higher return on invested capital (0.00% vs −606.9%). Across the 16 metrics below, Telesis Bio Inc. leads on 11 and Intelligent Bio Solutions Inc. on 5.

Valuation

Metric INBS TBIO Medical Devices median
P/E n/m n/m 22.18
P/S 0.59 n/m 2.70
P/B 0.47 n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.22 0.10 2.38
Earnings yield (530.59%) 0.00% (8.22%)
Free cash flow yield (488.15%) 0.00% (7.80%)

Profitability

Metric INBS TBIO Medical Devices median
Gross margin 48.64% 45.62% 56.01%
Operating margin (299.11%) (265.73%) (15.03%)
Net margin (294.91%) (287.90%) (20.40%)
Free cash flow margin (289.93%) (143.25%) (7.24%)
Return on equity (306.76%) 1,013.88% (15.32%)
Return on assets (123.13%) (73.87%) (19.72%)
Return on invested capital (606.86%) 0.00% (10.33%)

Growth

Metric INBS TBIO Medical Devices median
Revenue growth (TTM) 38.09% (38.09%) 8.80%
EPS growth (last fiscal year) 57.80% 0.61% —
Revenue growth, 5-year CAGR 16.31% 41.76% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INBS TBIO Medical Devices median
Debt to equity 0.00 (0.23) 0.07
Current ratio 1.44 1.23 2.50
Net debt to EBITDA 0.35 0.46 0.49

Dividend

Metric INBS TBIO Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric INBS TBIO Medical Devices median
Market cap 5.67m 5.31m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack